Brinter

Brinter presenting at BioFuture October 4-6, 2023 in NYC

https://www.brinter.com/biofuture

See CEO Tomi Alapaattikoski's presentation and meet us October 4-6 at Biofuture in New York, NY, where esteemed innovators and investors gather to assess and shape the future of healthcare.

If you are interested in learning more about Brinter’s ongoing investor round, our industry-changing cartilaginous bio-implants, enabled by our patented 3D biomanufacturing tech and our biosynthetic materials, please don’t hesitate to contact us. We will happily schedule a meeting with our Brinter Inc CEO Tom Alapaattikoski, at the conference or virtually.

“I am eager to be presenting this year at BioFuture in New York and meeting with the attending highly reputable LifeScience Investors.”

Tomi Alapaattikoski, CEO

You can learn more about the event here:�https://biofuture.com/about-the-event/

Brinter presenting at Biofuture October 4-6, 2023 in NYC Brinter presenting at Biofuture October 4-6, 2023 in NYC See Brinter’s presentation and meet us October 4-6 at Biofuture in New York, NY, where esteemed innovators and investors gather to assess and shape the future of healthcare.If you are interested in learning more about Brinter’s ongoing inv...

Brinter at Biotech CEO Summit – Strengthening Foundations for Growth

https://www.brinter.com/ceo-summit

Tomi Alapaattikoski, CEO and Co-founder of Brinter, a pioneering personalized bio-implant company, attended the private, invite-only Biotech CEO Summit in La Jolla, July 17-19, 2023.

With the theme “Strengthen Your Foundation, Prepare for Growth,” the invitational Biotech summit provided an ideal platform for industry’s top CEOs to define their company’s growth and financial strategies.

Brinter CEO Tom Alapaattikoski’s presence at the summit reaffirmed the company’s position as a key player in the biotech sector, receiving accolades for its exceptional innovation in the field. The company’s dedication to tissue therapeutics and personalized bio-implants garnered widespread praise, further fueling anticipation for their upcoming steps.

The Biotech CEO Summit served as a catalyst for Brinter to foster valuable connections with Biotech CEO’s and other industry peers, setting the stage for a promising future for the company.

Brinter at Biotech CEO Summit – Strengthening Foundations for Growth Brinter at Biotech CEO Summit – Strengthening Foundations for Growth Brinter at Biotech CEO Summit – Strengthening Foundations for Growth Brinter, a pioneering personalized bio-implant company, attended the private, invite-only Biotech CEO Summit in La Jolla, July 17-19, 2023. With the theme “...

PN Update: Brinter 3D bioprinter – Ease of use

Brinter 3D bioprinter - Ease of use Brinter® offers clear advantages in 3D bioprinting for the right price and is here to make 3D bioprinting mainstream in every lab and biomanufacturing plant in the world.

Check out our newly published book chapter in Elsevier’s Handbook of Surgical Planning and 3D printing discussing how 3D bioprinting can be used for future treatment of osteoarthritis!

https://www.brinter.com/elseviers

This chapter was written by an amazing team of scientists and engineers during the EU Horizon 2020 program funded RESTORE project, including Sanna Turunen, Tomi Kalpio, Carl Lindahl, Chirag Jain Mysore Shanthinathan, Tahsin Akhter, Sebastian Concaro and Stina Simonsson.

We hope that this book chapter will inspire next-generation 3D bioprinted cartilage replacements to ensure that osteoarthritis remains in the past.

University of Gothenburg, Sahlgrenska University Hospital, 3dheals

Published Book Chapter in Elsevier’s Handbook of Surgical Planning: A Collaborative Effort Towards Using 3D Bioprinting for Future Treatment of Osteoarthritis Published Book Chapter in Elsevier’s Handbook of Surgical Planning: A Collaborative Effort Towards Using 3D Bioprinting for Future Treatment of Osteoarthritis